- Acorda Therapeutics Announces Delisting from Nasdaq
- Acorda Therapeutics Announces Nasdaq Delisting Notification
- Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
- Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024
- Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
More ▼
Key statistics
On Friday, Acorda Therapeutics Inc (ACORQ:PKC) closed at 0.395, 58.00% above the 52 week low of 0.25 set on Apr 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.46 |
---|---|
High | 0.50 |
Low | 0.34 |
Bid | -- |
Offer | -- |
Previous close | 0.46 |
Average volume | 26.13k |
---|---|
Shares outstanding | 1.24m |
Free float | 1.23m |
P/E (TTM) | -- |
Market cap | 490.63k USD |
EPS (TTM) | -212.10 USD |
Data delayed at least 15 minutes, as of May 31 2024 20:44 BST.
More ▼